| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Chief Scientific Officer | Non-Qualified Stock Option (right to buy) | 123,559 | 05 Feb 2025 | Direct | ||
| PALVELLA THERAPEUTICS, INC. | Chief Scientific Officer | Stock Option (Right to Buy) | 64,318 | 05 Feb 2026 | Direct | ||
| PIERIS PHARMACEUTICALS, INC. | Chief Scientific Officer | Incentive Stock Option (right to buy) | 5,373 | 05 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVLA | PALVELLA THERAPEUTICS, INC. | 05 Feb 2026 | 1 | $0 | 4 | Chief Scientific Officer | 09 Feb 2026, 16:08 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 05 Feb 2025 | 2 | $0 | 4/A | Chief Scientific Officer | 10 Feb 2025, 18:00 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 13 Dec 2024 | 1 | $0 | 4 | Chief Scientific Officer | 17 Dec 2024, 20:44 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 13 Dec 2024 | 0 | $0 | 3 | Chief Scientific Officer | 16 Dec 2024, 19:42 |